Oramed (ORMP) to Conduct Sub-Study on Oral Insulin per FDA Request
Go back to Oramed (ORMP) to Conduct Sub-Study on Oral Insulin per FDA Request| ORAMED (NASDAQ: ORMP) | Delayed: 4.78 +0.21 (4.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.57 | 52 Week High | $10.74 | |||
| Open | $4.56 | 52 Week Low | $5.60 | |||
| Day High | $4.82 | P/E | N/A | |||
| Day Low | $4.48 | EPS | $-0.59 | |||
| Volume | 300,900 | |||||
